Maxiflo Rotacaps 100 mcg are inhalable dry-powder capsules containing fluticasone propionate, a potent inhaled corticosteroid, and formoterol fumarate, a long-acting β₂-agonist. These capsules are designed for use with a compatible DPI device to reduce airway inflammation and maintain open airways—supported by a portable, propellant-free format suitable for daily asthma and COPD management.
Select options
This product has multiple variants. The options may be chosen on the product page
Maxiflo Rotacaps 250 mcg are inhalable dry‑powder capsules containing a fixed dose of fluticasone propionate, a potent inhaled corticosteroid, and formoterol fumarate, a long-acting β₂‑agonist. These capsules work together to reduce airway inflammation and maintain open airways—ideal for daily management of asthma and COPD when used with a compatible DPI device.
Select options
This product has multiple variants. The options may be chosen on the product page
Medrol 16 mg contains methylprednisolone, a corticosteroid known for its potent anti-inflammatory and immunosuppressive effects. It is used in conditions such as moderate inflammation, autoimmune flare-ups, severe allergies, and respiratory disorders, providing significant relief when used as prescribed.
Medrol 4 mg contains methylprednisolone, a corticosteroid with effective anti-inflammatory and immunosuppressive properties. It is suitable for managing mild to moderate inflammation, allergic reactions, respiratory conditions, and immune-related disorders. The tablet form enables precise dosing, making it ideal for tailoring treatment duration as needed.
Medrol 8 mg contains methylprednisolone, a corticosteroid with significant anti-inflammatory and immunosuppressive properties. It’s appropriate for managing moderate inflammatory diseases, autoimmune flares, acute allergy symptoms, and certain respiratory conditions. The tablet form allows accurate dosing and flexible treatment duration under medical supervision.
Select options
This product has multiple variants. The options may be chosen on the product page
Methylprednisolone LP 4 mg is a controlled-release (LP) oral corticosteroid tablet formulated for sustained anti-inflammatory effect throughout the day. It is intended for conditions requiring consistent steroid delivery such as autoimmune diseases, severe allergic reactions, and chronic inflammatory disorders. The LP (long-acting) design helps maintain stable therapy levels.
Select options
This product has multiple variants. The options may be chosen on the product page
Montair 10 mg is a once-daily oral tablet containing montelukast, a leukotriene receptor antagonist that helps reduce airway inflammation and prevent bronchoconstriction. It’s indicated for adults and adolescents (15 years+) to manage chronic asthma, prevent exercise-induced bronchospasm, and alleviate seasonal or perennial allergic rhinitis.
Select options
This product has multiple variants. The options may be chosen on the product page
Montair Chewable 4 mg is a chewable tablet formulation of montelukast, a leukotriene receptor antagonist that helps reduce airway inflammation and allergic reactions. Designed for children aged 2–5, it assists in preventing airway constriction, exercise-induced asthma, and symptoms of seasonal allergic rhinitis with a dose that’s easy for little ones to take.
Select options
This product has multiple variants. The options may be chosen on the product page
Montair Chewable 5 mg is a chewable tablet containing montelukast, a leukotriene receptor antagonist that helps block inflammation and airway constriction. Indicated for children aged 6–14, it helps prevent asthma exacerbations, manage exercise-induced asthma, and alleviate seasonal or perennial allergy symptoms.
Select options
This product has multiple variants. The options may be chosen on the product page
Montair LC Kid is a chewable tablet combining montelukast, a leukotriene receptor antagonist that decreases airway inflammation, with levocetirizine, a third-generation antihistamine that reduces allergy symptoms like sneezing and itching. Formulated for children, it supports improved respiratory comfort and allergy management with convenient, enjoyable dosing.
Select options
This product has multiple variants. The options may be chosen on the product page
Montair Plus is an oral tablet that combines montelukast, a leukotriene receptor antagonist reducing airway inflammation, with bambuterol, a prodrug offering sustained β₂-agonist bronchodilation. This dual-action medication supports improved respiratory function, helping prevent asthma attacks, relieve bronchial constriction, and enhance control in chronic respiratory conditions.
Select options
This product has multiple variants. The options may be chosen on the product page
Seretide Accuhaler 50/100 mcg is a multi-dose dry powder inhaler (DPI) that combines salmeterol (a long-acting β₂‑agonist) and fluticasone propionate (a corticosteroid). Designed for regular use, this inhaler delivers sustained bronchodilation and inflammation suppression to enhance respiratory comfort in patients with asthma and COPD.
In order to provide you a personalized shopping experience, our site uses cookies. By continuing to use this site, you are agreeing to our cookie policy.